Market Research Logo

GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

The GCC generic injectables market was worth US$ 392 Million in 2017. The market is further projected to reach a value of US$ 776 Million by 2023, exhibiting a CAGR of 12.1% over the forecast period. Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use. They are used for treating a wide array of life-threatening and chronic diseases including diabetes, cancer, cardiovascular diseases, rheumatoid arthritis, respiratory diseases, osteoporosis, etc. In the GCC region, a rise in the prevalence of various lifestyle diseases has catalysed the uptake of generic injectables. The lower cost of these drugs compared to their branded equivalents further helps in providing substantial savings for the patients and healthcare providers.

GCC Generic Injectables Market Drivers/Constraints:

An increase in the emigrant population along with a rise in both acute and chronic diseases has challenged the capability of the existing healthcare resources in the region. The consequent surge in the overall healthcare costs has boosted the demand for generic injectables.
Upcoming patent expiry of a number of blockbuster drugs prescribed in key therapeutic areas is expected to help in expanding the product portfolio of generic injectable manufacturers.
The total number of manufacturers in the generic injectables market is limited as compared to oral generics. This results in lower price erosion and significantly higher margins.
Some of the other factors driving the generic injectables market in the region include a rising ageing population, development of the private healthcare market, improving standards of living, better awareness of health issues, etc.

Regional Insights:

Region-wise, Saudi Arabia represents the leading market, holding the largest market share. Other major regions include the UAE, Kuwait, Qatar, Oman and Bahrain.

Therapeutic Area Insights:

Based on the therapeutic area, oncology holds the largest market share. A rise in the number of cancer diagnoses coupled with improved access to treatment is currently driving the growth of this segment. Other major segments include anaesthesia, anti-infectives, cardiovascular and parenteral nutrition.

Distribution Channel Insights:

The market has also been divided on the basis of distribution channel as hospitals, clinics and retail pharmacy stores. Generic injectables are majorly distributed through hospitals.

Container Types:

On the basis of container type, the market has been segmented into vials, prefilled syringes, ampoules and premix. Currently, vials represent the major container type, accounting for the majority of the total market share.

Competitive Landscape:

The competitive landscape of the GCC generic injectables market along with the profiles of key players has also been analysed in the report.

This report provides a deep insight into the GCC generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the generic injectables industry in any manner.

Key Questions Answered in This Report:

How has the GCC generic injectables market performed so far and how will it perform in the coming years?
What are the key regional markets in the GCC generic injectables industry?
What are the key therapeutic areas in the GCC generic injectables industry?
What are the major distribution channels in the GCC generic injectables industry?
What are the major container types in the GCC generic injectables industry?
What are the various stages in the value chain of the GCC generic injectables industry?
What are the key driving factors and challenges in the GCC generic injectables industry?
What is the structure of the GCC generic injectables industry and who are the key players?
What is the degree of competition in the GCC generic injectables industry?
What are the profit margins in the GCC generic injectables industry?
What are the key requirements for setting up a generic injectables manufacturing plant?
How are generic injectables manufactured?
What are the various unit operations involved in a generic injectables manufacturing plant?
What is the total size of land required for setting up a generic injectables manufacturing plant?
What are the machinery requirements for setting up a generic injectables manufacturing plant?
What are the raw material requirements for setting up a generic injectables manufacturing plant?
What are the packaging requirements for generic injectables?
What are the transportation requirements for generic injectables?
What are the utility requirements for setting up a generic injectables manufacturing plant?
What are the manpower requirements for setting up a generic injectables manufacturing plant?
What are the capital costs for setting up a generic injectables manufacturing plant?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 GCC Generic Injectables Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Breakup by Therapeutic Area
5.5 Market Breakup by Container Type
5.6 Market Breakup by Distribution Channel
5.7 Market Forecast
5.8 SWOT Analysis
5.8.1 Strengths
5.8.2 Weaknesses
5.8.3 Opportunities
5.8.4 Threats
5.9 Value Chain Analysis
5.9.1 Research and Development
5.9.2 Manufacturing
5.9.3 Marketing and Distribution
5.10 Porter’s Five Forces Analysis
5.10.1 Overview
5.10.2 Bargaining Power of Supplier
5.10.3 Bargaining Power of Buyers
5.10.4 Degree of Competition
5.10.5 Threat of New Entrants
5.10.6 Threat of Substitutes
5.11 Price Analysis
5.11.1 Price Indicators
5.11.2 Margin Analysis
5.12 Key Market Drivers and Success Factors
6 Market Performance by Key Regions
6.1 Saudi Arabia
6.2 UAE
6.3 Kuwait
6.4 Qatar
6.5 Oman
6.6 Bahrain
7 Market Performance by Container Type
7.1 Vials
7.2 Prefilled Syringes
7.3 Ampoules
7.4 Premix
7.5 Others
8 Market Performance by Therapeutic Area
8.1 Oncology
8.2 Anaesthesia
8.3 Anti-infectives
8.4 Cardiovascular
8.5 Parenteral Nutrition
8.6 Others
9 Market Performance by Distribution Channel
9.1 Hospitals
9.2 Clinics
9.3 Retail Pharmacy Stores
10 Competitive Landscape
10.1 Competitive Structure
10.2 Key Players
11 Generic Injectable Manufacturing Process
11.1 Product Overview
11.2 Detailed Process Flow
11.3 Various Types of Unit Operations Involved
11.4 Mass Balance and Raw Material Requirements
12 Project Details, Requirements and Costs Involved
12.1 Land, Location and Site Development
12.2 Construction Requirements
12.3 Plant Machinery
12.4 Machinery Pictures
12.5 Raw Material Requirements
12.6 Raw Material and Final Product Pictures
12.7 Packaging Requirements
12.8 Transportation Requirements
12.9 Utility Requirements
12.10 Manpower Requirements
12.11 Other Capital Investments
13 Key Player Profiles
List of Figures
Figure 1: GCC: Generic Injectables Market: Major Drivers and Challenges
Figure 2: GCC: Generic Injectables Market: Sales Value (in Million US$), 2010-2017
Figure 3: GCC: Generic Injectables Market: Breakup by Region (in %), 2017
Figure 4: GCC: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2017
Figure 5: GCC: Generic Injectable Market: Breakup by Container Type (in %), 2017
Figure 6: GCC: Generic Injectables Market: Breakup by Distribution Channel (in %), 2017
Figure 7: GCC: Generic Injectables Market Forecast: Sales Value (in Million US$), 2018-2023
Figure 8: GCC: Generic Injectables Industry: SWOT Analysis
Figure 9: GCC: Generic Injectables Market: Value Chain Analysis
Figure 10: GCC: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 11: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 12: UAE: Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 13: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 14: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 15: Oman: Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 16: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 17: GCC: Generic Injectables (in Vials) Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 18: GCC: Generic Injectables (in Prefilled Syringes) Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 19: GCC: Generic Injectables (in Ampoules) Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 20: GCC: Generic Injectables (in Premix) Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 21: GCC: Generic Injectables (in Other Container Types) Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 22: GCC: Oncology, Anti-infectives and Anesthesia Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 23: GCC: Cardiovascular Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 24: GCC: Parenteral Nutrition Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 25: GCC: Other Generic Injectables Market: Sales Value (in Million US$), 2010, 2017 & 2023
Figure 26: GCC: Generic Injectables Market: Sales through Hospitals (in Million US$), 2010, 2017 & 2023
Figure 27: GCC: Generic Injectables Market: Sales through Clinics (in Million US$), 2010, 2017 & 2023
Figure 28: GCC: Generic Injectables Market: Sales through Clinics (in Million US$), 2010, 2017 & 2023
Figure 29: Generic Injectable Manufacturing Plant: Detailed Process Flow
Figure 30: Generic Injectable Manufacturing Process: Conversion Rate of Feedstocks
Figure 31: Generic Oncology Drug Manufacturing Plant: Tertiary Packaging
Figure 32: Generic Injectable Manufacturing Process: Breakup of Capital Costs (in %)
Figure 33: Generic Injectables Industry: Breakup of Profit Margins at Various Level of the Value Chain
List of Tables
Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2017 and 2023
Table 2: GCC: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2018-2023
Table 3: GCC: Generic Injectables Market Forecast: Breakup by Container Type (in Million US$), 2018-2023
Table 4: GCC: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2018-2023
Table 5: GCC: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2018-2023
Table 6: GCC: Generic Injectables Industry: Market Structure
Table 7: GCC: Generic Injectables Market: Key Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report